1. Evolution of anti-SARS-CoV-2 therapeutic antibodies;Almagro;Int. J. Mol. Sci.,2022
2. Humoral and T-cell response to SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab;Brill;JAMA Neurol.,2021
3. Severe acute respiratory syndrome coronavirus 2 third vaccine immune response in multiple sclerosis patients treated with ocrelizumab;Brill;Ann. Neurol.,2022
4. COVID-19 Treatment Guidelines Panel, 2021. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https://files.covid19treatmentguidelines.nih.gov/guidelines/archive/covid19treatmentguidelines-12-23-2021.pdf (2021, accessed February 10, 2023).
5. COVID-19 Treatment Guidelines Panel, 2023. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/ (2023, accessed February 10, 2023).